Possibia

2095158

Last Update Posted: 2019-11-18

Recruiting has ended

All Genders

accepted

18 Years +

440 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

This study will evaluate the long-term safety and efficacy of oxymetazoline hydrogen chloride (HCL) Cream 1.0% (AGN-199201) in patients with persistent erythema associated with rosacea.

Eligibility

Relevant conditions:

Erythema

Rosacea

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov